In a report released yesterday, Naureen Quibria from Maxim Group maintained a Buy rating on Fennec Pharmaceuticals (FENC), with a price target of ...
The post Maxim Group Sticks to Its Buy Rating for Fennec Pharmaceuticals (FENC) appeared first on Smarter Analyst.
In a report released yesterday, ...

https://www.smarteranalyst.com/new-blurbs/maxim-group-sticks-to-its-buy-rating-for-fennec-pharmaceuticals-fenc/

#SmarterAnalyst